Reactivation of Hepatitis B Virus in Rheumatologic Patients Receiving Immunosuppressive Agents

Digestive Diseases and Sciences - United States
doi 10.1007/s10620-006-9609-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: A Hidden Menace

Hepatology International
Hepatology
2017English

Hepatitis B Reactivation in Patients Receiving Cytotoxic Chemotherapy - Diagnosis and Management

Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2009English

Evaluation of Hepatitis B Virus Serology, Antiviral Use and Reactivation Hepatitis in Hematologic Malignancy Patients

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2020English

Reactivation of Hepatitis B Virus Without Core Antibody

Journal of Clinical Microbiology
Microbiology
2015English

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)

Viruses
VirologyInfectious Diseases
2019English

Psy1 - Risk of Liver Enzyme Elevation in Autoimmune Patients With Different Hepatitis B Virus Infection Status Receiving Biologic Agents

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Hepatitis B Virus Reactivation in Transplant Patients Treated for Hepatitis C Recurrence: Prophylaxis Makes the Difference

Journal of Hepatology
Hepatology
2019English

Reactivation of Hepatitis B Virus Associated With Immunosuppression Therapy

CMAJ
Medicine
2018English

Evolution of Hepatitis B Virus Polymerase Gene Mutations in Hepatitis B E Antigen–Negative Patients Receiving Lamivudine Therapy

Hepatology
MedicineHepatology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy